Literature DB >> 22785152

Different influences of left ventricular remodeling on anterior and posterior mitral leaflet tethering.

Hiromi Nakai1, Kyoko Kaku, Masaaki Takeuchi, Kyoko Otani, Hidetoshi Yoshitani, Nobuhiko Haruki, Masahito Tamura, Masahiro Okazaki, Haruhiko Abe, Akizumi Tsutsumi, Robert A Levine, Yutaka Otsuji.   

Abstract

BACKGROUND: Different influences of left ventricular (LV) remodeling on anterior and posterior mitral leaflet (AML and PML) tethering in ischemic mitral regurgitation (MR) has not been fully investigated. We hypothesized that progressive outward displacement of papillary muscles, including posterior vector, may cause greater tethering to PML compared to AML. METHODS AND
RESULTS: In 79 patients with LV ejection fraction <50% and 20 controls, LV sphericity, AML and PML tethering angles, apical and posterior displacement of coaptation, mitral annular area, and severity of MR (vena contracta width) were measured using 3-D echocardiography. To examine different influences of LV remodeling on AML and PML tethering, interaction between AML/PML and LV sphericity was tested using multiple regression analysis. Both AML and PML tethering significantly increased with increased LV sphericity (r=0.59 and 0.65, P<0.001). Multiple regression yielded a significant interaction term between AML vs. LV sphericity and PML vs. LV sphericity (t=3.69, P<0.001), indicating greater influence from LV remodeling on PML compared to that for the AML. Multivariate analysis demonstrated independent contributions to MR severity from PML tethering primarily along with posterior and apical displacement of coaptation.
CONCLUSIONS: LV remodeling augments tethering of both AML and PML, with greater influence on PML.

Entities:  

Mesh:

Year:  2012        PMID: 22785152     DOI: 10.1253/circj.cj-11-1527

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

Review 1.  Ischemic and functional mitral regurgitation in heart failure: natural history and treatment.

Authors:  Mina M Benjamin; Robert L Smith; Paul A Grayburn
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

Review 2.  Benefits of submitral procedures for ischemic mitral regurgitation.

Authors:  Satoru Wakasa; Yoshiro Matsui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-15

3.  Surgical strategy for ischemic mitral regurgitation adopting subvalvular and ventricular procedures.

Authors:  Satoru Wakasa; Yasushige Shingu; Tomonori Ooka; Hiroki Katoh; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-02-16       Impact factor: 1.520

4.  Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.

Authors:  Shuichi Kitada; Tomoko S Kato; Sunu S Thomas; Suzanne D Conwell; Cesare Russo; Marco R Di Tullio; Maryjane Farr; P Christian Schulze; Nir Uriel; Ulrich P Jorde; Hiroo Takayama; Yoshifumi Naka; Shunichi Homma; Donna M Mancini
Journal:  J Heart Lung Transplant       Date:  2013-07-11       Impact factor: 10.247

5.  Ischemic Mitral Regurgitation: Current Understanding and Surgical Options.

Authors:  Alexander Angelo Brescia; Tessa Maria Fontana Watt; Steven Frederic Bolling
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-04-06

6.  Numerical prediction of thrombus risk in an anatomically dilated left ventricle: the effect of inflow cannula designs.

Authors:  Sam Liao; Benjamin Simpson; Michael Neidlin; Tim A S Kaufmann; Zhiyong Li; Maria A Woodruff; Shaun D Gregory
Journal:  Biomed Eng Online       Date:  2016-12-28       Impact factor: 2.819

7.  Commentary: The mitral valve and the left ventricle in functional mitral regurgitation: The puppet and the puppeteer.

Authors:  Dongyang Xu; Muralidhar Padala
Journal:  JTCVS Open       Date:  2020-12-07

8.  Usefulness of three-dimensional spherical index to assess different types of left ventricular remodeling: A meta-analysis.

Authors:  Decai Zeng; Hui Chen; Chun Lan Jiang; Ji Wu
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.